7 June 2023 – EyRIS is thrilled to be selected to participate in a ground-breaking tripartite partnership with The International Centre for Eye Health at the London School of Hygiene and Tropical Medicine, University of London and Tanzanian Ministry of Health. This collaboration aims to validate the use of Artificial Intelligence in screening for diabetic retinopathy (DR) in low-resource settings….
5 June 2023 – EyRIS is thrilled to announce our collaboration with Sao Rafael Hospital which is part of the renowned Rede D’Or São Luiz healthcare network in Brazil. This partnership underlines Rede D’Or São Luiz’s determination in improving patient care through state-of-the-art AI technology. By leveraging on SELENA+’s proven algorithms, Rede D’Or São Luiz aims to expand screening and…
2 June 2023 – EyRIS participated in another community outreach program, this time jointly organized by the Singapore Buddhist Youth Mission Temple and Diabetes Singapore, under the tagline “Healthiness is a Blessing”, aptly on Vesak Day. Worshippers were given the opportunity health check and experince EyRIS latest seamless workflow, which captures the fundus image and return the SELENA+ results of…
NOVA MSC BERHAD 01 June 2023 Type Announcement Subject MEMORANDUM OF UNDERSTANDING Description EyRIS and Optometrist Warehouse signed MOU to collaborate on study focused on the effectiveness of AI in screening diabetic retinopathy in Australia Please find attached Press Release in respect of the signing of a Memorandum of Understanding (“MOU”) between (i) Eyris Pte Ltd (“Eyris”), which is…
NOVA MSC BERHAD 01 June 2023 Type Announcement Subject OTHERS Description Nova MSC Berhad (NOVAMSC or Company) – ACE Market Listing Requirements for at least 1 woman director on board NOVAMSC wishes to inform that our Board of Directors (“Board”) as at the date of this announcement is an all-male board of directors, and the Company is in the…
1 June 2023 – EyRIS, a pioneering company in artificial intelligence (AI) healthcare solutions, and Optometrist Warehouse, part of the Chemist Warehouse Group in Australia, have signed a Memorandum of Understanding (MOU) to collaborate on a ground-breaking study focused on the effectiveness of AI in screening diabetic retinopathy. This collaboration marks a significant milestone in the field of healthcare, showcasing…
May 2023 – We are thrilled to announce that SELENA+ has successfully attained regulatory approval from the Ministry of Health & Prevention, United Arab Emirates (UAE). market At nearly 19%, UAE has one of the world’s highest rates of diabetes. With diabetes comes complications such as diabetes retinopathy (DR) which left untreated can lead to blindness. It is well-documented that…
May 2023 – EyRIS is excited to announce our partnership with VUNO which supplies VUNO Med-Fundus AI, a complimentary AI solution used for detection of 12 fundus abnormalities. This innovation promises to contribute to a holistic AI offering on the EyRIS platform. This strategic partnership between VUNO and EyRIS brings value to the eye screening community as it provides an…
NOVA MSC BERHAD 31 May 2023 Financial Year End 31 Mar 2023 Quarter 4 Qtr Quarterly report for the financial period ended 31 Mar 2023 The figures have not been audited
NOVA MSC BERHAD 19 May 2023 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 53,500 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$) (if…
Apr 2023 – Panaga Health Centre (PHC), Brunei Darussalam opened in 1968 to provide quality medical and health services to the employees of Brunei Shell Petroleum (BSP) along with their dependents and also the public. Primarily, PHC is a primary health centre that operates emergency services together with ancillary departments such as laboratory, diagnostic imaging and occupational health. To improve…
NOVA MSC BERHAD 28 March 2023 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 120,000 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$) (if…